Clovis Oncology reported $631M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Abbvie ABBV:US $ 73474M 3210M
Acadia Pharmaceuticals ACAD:US $ 0M 0M
Acorda Therapeutics ACOR:US $ 182.44M 3.77M
Agenus AGEN:US $ 14.18M 0.63M
Agios Pharmaceuticals AGIO:US $ 0.53M 0.08M
Anika Therapeutics ANIK:US $ 0.12M 0.07M
Arrowhead Research ARWR:US $ 0M 0M
AstraZeneca AZN:LN 31099M 318M
Astrazeneca AZN:US $ 31099M 318M
Cerulean Pharma CERU:US $ 0M 0M
Clovis Oncology CLVS:US $ 631M 15.77M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Esperion Therapeutics ESPR:US $ 258.68M 398K
GlaxoSmithKline GSK:LN 33328M 9155M
Halozyme Therapeutics HALO:US $ 877.64M 0.97M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Insmed INSM:US $ 806.79M 225.49M
Intrexon XON:US $ 201.47M 18.32M
Ligand Pharmaceuticals LGND:US $ 176.59M 144.17M
Merk MRK:US $ 31794M 1308M
Mirati Therapeutics MRTX:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 377.7M 42.6M
Novartis NOVN:VX SF 31275M 250M
Pfizer PFE:US $ 36301M 2135M
Puma Biotechnology PBYI:US $ 97.38M 0.29M
Rigel Pharmaceuticals RIGL:US $ 29.85M 9.93M
Sangamo Biosciences SGMO:US $ 0M 0M
Seattle Genetics SGEN:US $ 0M 0M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.98M
Veracyte VCYT:US $ 1.68M 0.05M
YTE INCY:US $ 34.18M 0.09M